Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongbo Yang

Showing results (201-210 of 471) with videos related to

Pageof 48
Sort By:
Nature Ecology & Evolution|April 22, 2025
Global breeding programme benefits wild panda conservationHongbo Yang, Qiongyu Huang, Ruishan Chen, et al.
Journal of Medical Economics|April 9, 2026
Cost-effectiveness of exagamglogene autotemcel gene-edited therapy in patients with transfusion-dependent <b><i>β</i></b>-thalassemia in the United StatesChuka Udeze, Michael Gargano, Hongbo Yang, et al.
Journal of Managed Care & Specialty Pharmacy|June 8, 2019
Health Care Resource Utilization and Costs Associated with Corticosteroid Use in Patients with Castration-Resistant Prostate Cancer: An Administrative Claims AnalysisNeil M Schultz, David F Penson, Samuel D Wilson, et al.
Physical Review Letters|December 31, 2005
Two- to three-dimensional crossover in the electronic structure of (Bi, Pb)2(Sr, La)2CuO(6+delta) from angle-resolved photoemission spectroscopyTsunehiro Takeuchi, Takeshi Kondo, Takio Kitao, et al.
Advances in Therapy|December 3, 2025
Economic Burden of Primary Biliary Cholangitis by Line of Therapy in the United StatesSonal Kumar, Nisreen Shamseddine, Hongbo Yang, et al.
Leukemia & Lymphoma|November 21, 2022
Healthcare resource use and reimbursement amount by site of care in patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell (CAR-T) therapy - a retrospective cohort study using CMS 100% Medicare claims databaseHongbo Yang, Vamsi Bollu, Stephen Lim, et al.
Clinical Therapeutics|April 2, 2017
Clinical Outcomes Associated with Switching or Discontinuation from Anti-TNF Inhibitors for Nonmedical ReasonsDouglas Wolf, Martha Skup, Hongbo Yang, et al.
European Journal of Neurology|July 11, 2024
Effectiveness of patisiran after switching from tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathyCeline Labeyrie, Madeline Merkel, Sakshi Sethi, et al.
Journal of Medical Economics|February 23, 2026
Cost-effectiveness of exagamglogene autotemcel gene-edited therapy in patients with sickle cell disease with recurrent vaso-occlusive crises in the United StatesAndrea Lopez, Michael Gargano, Hongbo Yang, et al.
Advances in Therapy|December 4, 2016
Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive AspergillosisRachel Harrington, Edward Lee, Hongbo Yang, et al.
Pageof 48

Showing results (201-210 of 471) with videos related to

Sort By:
Pageof 48
Nature Ecology & Evolution|April 22, 2025
Global breeding programme benefits wild panda conservationHongbo Yang, Qiongyu Huang, Ruishan Chen, et al.
Journal of Medical Economics|April 9, 2026
Cost-effectiveness of exagamglogene autotemcel gene-edited therapy in patients with transfusion-dependent <b><i>β</i></b>-thalassemia in the United StatesChuka Udeze, Michael Gargano, Hongbo Yang, et al.
Journal of Managed Care & Specialty Pharmacy|June 8, 2019
Health Care Resource Utilization and Costs Associated with Corticosteroid Use in Patients with Castration-Resistant Prostate Cancer: An Administrative Claims AnalysisNeil M Schultz, David F Penson, Samuel D Wilson, et al.
Physical Review Letters|December 31, 2005
Two- to three-dimensional crossover in the electronic structure of (Bi, Pb)2(Sr, La)2CuO(6+delta) from angle-resolved photoemission spectroscopyTsunehiro Takeuchi, Takeshi Kondo, Takio Kitao, et al.
Advances in Therapy|December 3, 2025
Economic Burden of Primary Biliary Cholangitis by Line of Therapy in the United StatesSonal Kumar, Nisreen Shamseddine, Hongbo Yang, et al.
Leukemia & Lymphoma|November 21, 2022
Healthcare resource use and reimbursement amount by site of care in patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell (CAR-T) therapy - a retrospective cohort study using CMS 100% Medicare claims databaseHongbo Yang, Vamsi Bollu, Stephen Lim, et al.
Clinical Therapeutics|April 2, 2017
Clinical Outcomes Associated with Switching or Discontinuation from Anti-TNF Inhibitors for Nonmedical ReasonsDouglas Wolf, Martha Skup, Hongbo Yang, et al.
European Journal of Neurology|July 11, 2024
Effectiveness of patisiran after switching from tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathyCeline Labeyrie, Madeline Merkel, Sakshi Sethi, et al.
Journal of Medical Economics|February 23, 2026
Cost-effectiveness of exagamglogene autotemcel gene-edited therapy in patients with sickle cell disease with recurrent vaso-occlusive crises in the United StatesAndrea Lopez, Michael Gargano, Hongbo Yang, et al.
Advances in Therapy|December 4, 2016
Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive AspergillosisRachel Harrington, Edward Lee, Hongbo Yang, et al.
Pageof 48